Cargando…
Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
Patients with chronic heart failure (HF) have a poor prognosis due to irreversible impairment of left ventricular function, with 5-year survival rates <60%. Despite advances in conventional medicines for HF, prognosis remains poor, and there is a need to improve treatment further. Cell-based ther...
Autores principales: | Kishino, Yoshikazu, Fukuda, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046277/ https://www.ncbi.nlm.nih.gov/pubmed/36979894 http://dx.doi.org/10.3390/biomedicines11030915 |
Ejemplares similares
-
Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022) -
Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
por: Tanosaki, Sho, et al.
Publicado: (2021) -
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
por: Kishino, Yoshikazu, et al.
Publicado: (2020) -
The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
por: Soma, Yusuke, et al.
Publicado: (2021) -
Establishment and Industrialization of a New Treatment Method Using Regenerative Cardiomyocyte Transplantation for Refractory Severe Heart Failure - Secondary Publication
por: Fukuda, Keiichi
Publicado: (2023)